GGrantIndex
← Leaderboards

George Norbert Cox

Bolder Biotechnology, Inc.

Google Scholar ↗PubMed ↗ORCID ↗
$22,120,941
Attributed
$23,583,101
Total exposure
26
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY2005–24
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$23,583,101 · 26

By mechanism

R44$16,544,516 · 14
R43$4,114,265 · 11
U01$2,924,320 · 1

Top collaborators

Others in their field

Top investigators on “Grant”

Research focus

GrantDoseAnimalsProteinsHalf-LifeDrug KineticsGovernmentAnalogAnemiaHealth PersonnelPolyethylene GlycolsThrombocytopeniaIn VivoRattusEmergency SituationNeutropeniaBasePropertyCell TypeDesignNational Institute Of Allergy And Infectious DiseaseAnimal ModelProductionTissues

Grant awards (51)

Novel drug combinations for improving survival from acute radiation syndrome when administered 48 hours post- irradiation$717,432
R44 · FY2024 · AI · contact PI
Improving survival from Burkholderia pseudomallei and other pathogenic intracellular bacteria$295,924
R43 · FY2024 · AI · contact PI
Novel drug combinations for improving survival from acute radiation syndrome when administered 48 hours post- irradiation$1,000,000
R44 · FY2023 · AI · contact PI
Stimulating innate immunity to protect against Ebola virus infection$300,000
R43 · FY2021 · AI · contact PI
Novel drugs combinations for improving survival from Acute Radiation Syndrome when administered 48h postirradiation$293,507
R43 · FY2020 · AI · contact PI
Novel drugs combinations for improving survival from Acute Radiation Syndrome when administered 48h postirradiation$300,000
R43 · FY2019 · AI · contact PI
Long-acting growth factors for treating the acute and long term effects of lethal$476,768
U01 · FY2017 · AI · contact PI
Long-acting growth factors for treating the acute and long term effects of lethal$674,036
U01 · FY2016 · AI · contact PI
Long-Acting G-CSF Analog for Treating ARS$1,196,000
R44 · FY2015 · AI · contact PI
Long-acting growth factors for treating the acute and long term effects of lethal$553,403
U01 · FY2015 · AI · contact PI
Long-Acting G-CSF Analog for Treating ARS$1,000,000
R44 · FY2014 · AI · contact PI
Long-acting growth factors for treating the acute and long term effects of lethal$731,319
U01 · FY2014 · AI · contact PI
Long-Acting G-CSF Analog for Treating ARS$1,000,000
R44 · FY2013 · AI · contact PI
Long-acting growth factors for treating the acute and long term effects of lethal$488,794
U01 · FY2013 · AI · contact PI
Long-Acting IL-11 Analog for Treating Acute Radiation Syndrome$300,000
R43 · FY2011 · AI · contact PI
Long-acting EPO analog for treating anemia associated with chronic kidney disease$472,707
R44 · FY2010 · DK · contact PI
Long-Acting IL-11 Analog for Treating Acute Radiation Syndrome$300,000
R43 · FY2010 · AI · contact PI
GM-CSF analogs for treating acute radiation syndrome$299,943
R43 · FY2010 · AI · contact PI
Long-Acting G-CSF analogs for treating acute radiation syndrome$299,927
R43 · FY2010 · AI · contact PI
Long-acting Growth Hormone for Treating HIV-Associated Adipose Redistribution Syn$1,000,000
R44 · FY2009 · AI · contact PI
Long Acting Beta Interferon for Treating Multiple Sclerosis - Phase II Continuing$790,800
R44 · FY2009 · NS · contact PI
Long-acting EPO analog for treating anemia associated with chronic kidney disease$767,785
R44 · FY2009 · DK · contact PI
GM-CSF analogs for treating acute radiation syndrome$299,958
R43 · FY2009 · AI · contact PI
Long-Acting G-CSF analogs for treating acute radiation syndrome$299,958
R43 · FY2009 · AI · contact PI
Long-acting Growth Hormone for Treating HIV-Associated Adipose Redistribution Syn$976,501
R44 · FY2008 · AI · contact PI
Long Acting Beta Interferon for Treating Multiple Sclerosis - Phase II Continuing$826,535
R44 · FY2008 · NS · contact PI
Long Acting IFN-gamma for Treating Immunodeficiencies$398,910
R44 · FY2008 · AI · contact PI
Long Acting VEGF Binding Proteins for Treating Rheumatoid Arthritis$347,061
R44 · FY2008 · AR · contact PI
Long Acting IFN-gamma for Treating Immunodeficiencies$363,565
R44 · FY2007 · AI · contact PI
Long Acting VEGF Binding Proteins for Treating Rheumatoid Arthritis$338,923
R44 · FY2007 · AR · contact PI
Long Acting VEGF BInding Proteins for Treating Cancer$335,148
R44 · FY2007 · CA · contact PI
Long Acting VEGF BInding Proteins for Treating Cancer$440,699
R44 · FY2006 · CA · contact PI
Long-Acting Beta Interferon for Multiple Scierosis$376,561
R44 · FY2005 · NS
Long Acting EPO For Treating Chronic Kidney Disease$250,000
R43 · FY2005 · DK
Long-Acting IFN-gamma for Treating Ovarian Cancer$121,844
R43 · FY2005 · CA
Long-Acting Beta Interferon for Multiple Scierosis$373,337
R44 · FY2004 · NS
Long-Acting Growth Hormone For HIV-Associated Wasting$303,204
R43 · FY2004 · AI
Long Acting EPO For Treating Chronic Kidney Disease$250,000
R43 · FY2004 · DK
Cytokine Conjugates For Treating Thrombocytopenia$385,453
R44 · FY2003 · CA
Cytokine Conjugates For Treating Thrombocytopenia$412,925
R44 · FY2002 · CA
LONG-ACTING G-CSF PROTEINS FOR TREATING NEUTROPENIA$367,811
R44 · FY2002 · CA
LONG ACTING GCSF PROTEINS FOR TREATING NEUTROPENIA$403,950
R44 · FY2001 · CA
LONG ACTING ERYTHROPOIETIN PROTEINS FOR TREATING ANEMIA$304,100
R44 · FY2001 · DK
GROWTH FACTOR CONJUGATES FOR TREATING HORMONAL DISEASES$295,575
R44 · FY2001 · DK
LONG-ACTING INTERFERON FOR VIRAL DISEASES AND CANCER$251,478
R44 · FY2001 · CA
LONG-ACTING BETA INTERFERON FOR MULTIPLE SCLEROSIS$100,000
R43 · FY2001 · NS
LONG ACTING ERYTHROPOIETIN PROTEINS FOR TREATING ANEMIA$433,900
R44 · FY2000 · DK
LONG-ACTING INTERFERON FOR VIRAL DISEASES AND CANCER$399,339
R44 · FY2000 · CA
GROWTH FACTOR CONJUGATES FOR TREATING HORMONAL DISEASES$298,760
R44 · FY2000 · DK
LONG-ACTING GH FOR SHORT STATURE AND CACHEXIA$269,261
R44 · FY2000 · DK
CYTOKINE CONJUGATES FOR TREATING THROMBOCYTOPENIA$100,000
R43 · FY2000 · CA